Omnicell
Omnicell, Inc., headquartered in the United States, is a leading provider of medication management solutions and automation systems for healthcare facilities. Founded in 1992, the company has established itself as a key player in the healthcare technology industry, focusing on optimising pharmacy operations and enhancing patient safety. With a strong presence across North America and expanding operations in international markets, Omnicell offers a range of innovative products, including automated dispensing systems and medication adherence solutions. These offerings are designed to streamline workflows and reduce medication errors, setting Omnicell apart in a competitive landscape. Recognised for its commitment to improving healthcare efficiency, Omnicell has achieved significant milestones, including numerous awards for innovation and excellence in service delivery. As the demand for advanced healthcare solutions continues to grow, Omnicell remains at the forefront, dedicated to transforming medication management for providers and patients alike.
DitchCarbon Score
How does Omnicell's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Omnicell's score of 39 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Omnicell's reported carbon emissions
In 2024, Omnicell reported total carbon emissions of approximately 5,245,000 kg CO2e, comprising 335,000 kg CO2e from Scope 1 and 4,910,000 kg CO2e from Scope 2 emissions. This reflects a decrease from 2023, where emissions totalled about 5,542,000 kg CO2e, with Scope 1 emissions at 392,000 kg CO2e and Scope 2 emissions at 5,149,000 kg CO2e. Over the past few years, Omnicell's emissions have shown fluctuations, with 2022 emissions recorded at approximately 6,387,000 kg CO2e, including 475,000 kg CO2e from Scope 1 and 5,912,000 kg CO2e from Scope 2. The company has not disclosed any Scope 3 emissions data. Despite these figures, Omnicell has not set specific reduction targets or initiatives as part of their climate commitments, nor have they reported any SBTi (Science Based Targets initiative) reduction targets. The absence of documented reduction initiatives suggests a need for further development in their climate strategy. Omnicell's emissions data is sourced directly from the organisation itself, with no cascaded data from a parent company. The company continues to focus on improving its carbon footprint while navigating the complexities of emissions reporting in the healthcare technology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 236,000 | 000,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | 11,609,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Omnicell is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
